Page last updated: 2024-08-16

ribavirin and Dermatitis Medicamentosa

ribavirin has been researched along with Dermatitis Medicamentosa in 63 studies

Research

Studies (63)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (3.17)	18.2507
2000's	26 (41.27)	29.6817
2010's	35 (55.56)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aggarwal, M; Bhari, N; Gupta, M	1
Campo-Cerecedo, F; Grueiro, MC; Monteagudo, B; Vilas-Sueiro, A	1
Aguilera, V; Berenguer, M; Vinaixa, C	1
Schmutz, JL; Trechot, P	1
Aoki, K; Kumada, H; Ohtsuki, M; Sakurai, Y; Sueki, H; Torii, H; Yamada, I	1
Arends, JE; Dutilh, JC	1
Planas, R; Tural, C	1
Macías, J; Rivero, A	1
Hézode, C	1
Markulin, A; Morović, M; Patrk, I; Patrk, J	1
Harada, N; Hayashi, N; Hiramatsu, N; Imai, Y; Inui, Y; Kaneko, A; Kasahara, A; Miyagi, T; Morishita, N; Oshita, M; Oze, T; Suzuki, K; Takehara, T; Tamura, S; Tatsumi, T; Yakushijin, T; Yamada, A; Yamada, R; Yoshida, Y; Yoshihara, H	1
Acero Fernández, D; Ferri Iglesias, MJ; Figa Francesch, M; Hombrados Verde, M; López Nuñez, C; Louvriex Freire, R; Virolés Torrent, S	1
Bernard, PH; Bernardeschi, C; Duclos-Vallée, JC; Dupin, N; Gressier, L; Hezode, C; Mallet, V; Milpied, B; Ortonne, N; Pol, S; Samuel, D; Valeyrie-Allanore, L; Wallet-Faber, N	1
Andrade, RJ; Buti, M; Casado, MA; Gros, B; Oyagüez, I; Serra, MA; Turnes, J	1
Arizumi, T; Chishina, H; Hagiwara, S; Inoue, T; Kitai, S; Kouno, M; Kudo, M; Minami, Y; Takita, M; Ueshima, K; Yada, N	1
Bielsa Marsol, I; Carrascosa Carrillo, JM; Ferrándiz Foraster, C; López Escartin, D; Masnou Ridaura, H; Morillas Cunill, R; Plana Pla, A; Planas Vilà, R; Toro Montecinos, M; Vilavella Rius, M	1
Kalsekar, A; Le, TK; Macaulay, D; Sorg, RA; Wei, J; Wu, EQ; Yuan, Y	1
Botta, D; Gaudy-Marqueste, C; Grob, JJ; Lorcy, S; Mancini, J; Oulies, V; Portal, I; Quiles, N; Richard, MA	1
Chadwick, PW; Heymann, WR	1
de Aguiar, MC; do Carmo, MA; Grossmann, Sde M; Teixeira, R	1
Borrego, L; Guillermo, N; Hernández Santana, J; Jorge, M	1
Behnam, SE; Fife, DJ; Hindiyeh, R; Jeffes, EW; Wu, JJ	1
Iijima, M; Sato, M; Sueki, H	1
Crawford, RI; Mistry, N; Shapero, J	1
Borum, ML; Igiehon, E; Shafa, S	1
Cardot-Leccia, N; Lacour, JP; Montaudié, H; Passeron, T; Sebbag, N	1
Di Lernia, V	1
Castellano Tortajada, G; Castellanos González, M; Muñoz Gómez, R; Pérez Carreras, M	1
Mandell, BF	1
Tang, DM; Ward, L	1
Bagree, A; Tavakoli-Tabasi, S	1
Chayama, K; Hayashi, N; Kumada, H; Okanoue, T; Toyota, J; Tsubouchi, H	1
Bourlière, M; Buggisch, P; Cacoub, P; Dupin, N; Dusheiko, G; Hézode, C; Lübbe, J; Picard, O; Pujol, R; Roujeau, JC; Segaert, S; Thio, B	1
Azuma, K; Dohmen, K; Furusyo, N; Hayashi, J; Kajiwara, E; Kotoh, K; Maruyama, T; Nakamuta, M; Nomura, H; Ogawa, E; Satoh, T; Shimoda, S; Takahashi, K; Tanabe, Y	1
Battyáni, Z; Hunyady, B; Kovács, B	1
Buti, M; Homs, M	1
Crespo, G; Lens, S	1
Barritt, AS; Fried, MW	1
Debbiche, A; Fenniche, S; Kerkeni, N; Marrak, H; Mlika, RB; Mokhtar, I	1
Blanc, F; Dereure, O; Guilhou, JJ; Larrey, D; Raison-Peyron, N	1
Kerl, K; Lübbe, J; Negro, F	1
Kaplan, AL; Sidhu-Malik, NK	1
Carter, DJ; Elpern, DJ; Moore, MM	1
Manjón-Haces, JA; Pérez-Alvarez, R; Pérez-Oliva, N; Vázquez-López, F	1
Bolognini, S; Careddu, GF; Cottoni, F; Deplano, A; Garrucciu, G; Lissia, A; Manzoni, NE; Montesu, MA; Solinas, A; Tocco, A	1
Chamberlain, AJ; Poon, E	1
Izumi, N	1
Blanco, JR; Metota, L; Oteo, JA; Rosel, L	1
Bessis, D; Blatìre, V; Girard, C; Guilhou, JJ; Guillot, B	1
Karaman, G; Karaoğlu, AO; Savk, E; Sendur, N; Uslu, G	1
Conde-Taboada, A; Cruces, MJ; de la Torre, C; Feal, C; Gonzalez-Sixto, B; Mayo, E	1
Kerl, K; Lübbe, J; Negro, F; Saurat, JH	1
Camacho, F; García-Bravo, B; Ruiz de Casas, A	1
Janssen, HL; Schalm, SW; Veldt, BJ	1
Hashimoto, Y; Itoh, M; Kanto, H	1
Akgun, H; Baskol, M; Gursoy, S; Guven, K; Ozbakir, O; Torun, E; Yucesoy, M; Yurci, A	1
Alpat, SN; Kartal, ED; Ozgunes, I; Usluer, G	1
Lübbe, J	1
Castaño, G; Chohuela, E; Frider, B; Kien, MC; Neglia, V; Sookoian, S	1
Antunes, I; Azevedo, F; Fernandes, N; MacEdo, G; Mesquita-Guimarães, J; Resende, C	1
Beylot, C; Beylot-Barry, M; Cogrel, O; Couzigou, P; Doutre, MS; Marlière, V	1
Belaich, S; Crickx, B; Descamps, V; Grossin, M; Le Bozec, P; Marcellin, P; Wendling, J	1
Janai, HK; Marks, MI; Stutman, HR; Zaleska, M	1

Reviews

15 review(s) available for ribavirin and Dermatitis Medicamentosa

Article	Year
[Progress in hepatitis C treatment]. Medicina clinica, 2013, Nov-16, Volume: 141, Issue:10 Topics: Anemia; Antiviral Agents; Clinical Trials, Phase III as Topic; Drug Eruptions; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Liver Transplantation; Multicenter Studies as Topic; Oligopeptides; Polyethylene Glycols; Proline; Protease Inhibitors; Pruritus; Randomized Controlled Trials as Topic; Recurrence; Ribavirin; RNA, Viral; Treatment Outcome; Viral Load; Viremia	2013
[Telaprevir-induced pityriasis rubra pilaris]. Annales de dermatologie et de venereologie, 2013, Volume: 140, Issue:5 Topics: Adrenal Cortex Hormones; Adult; Antiviral Agents; Biopsy; Drug Eruptions; Drug Therapy, Combination; Eosinophilia; Eosinophils; Hepacivirus; Hepatitis C, Chronic; Histamine Antagonists; Humans; Interferon-alpha; Keratinocytes; Lymphocytes; Middle Aged; Oligopeptides; Pityriasis Rubra Pilaris; Polyethylene Glycols; Protease Inhibitors; Recombinant Proteins; Ribavirin; Skin; Viral Nonstructural Proteins	2013
[Clinical use of telaprevir: stopping rules, predicting response, treatment length, and management of adverse effects]. Enfermedades infecciosas y microbiologia clinica, 2013, Volume: 31 Suppl 3 Topics: Anemia; Antiviral Agents; Clinical Trials as Topic; Drug Eruptions; Exanthema; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Interleukins; Liver Cirrhosis; Medical Futility; Multicenter Studies as Topic; Oligopeptides; Polyethylene Glycols; Protease Inhibitors; Ribavirin; RNA, Viral; Stevens-Johnson Syndrome; Viral Load	2013
[Safety and efficacy of telaprevir in patients with HIV and hepatitis C virus coinfection]. Enfermedades infecciosas y microbiologia clinica, 2013, Volume: 31 Suppl 3 Topics: Anti-HIV Agents; Antiviral Agents; CD4 Lymphocyte Count; Dose-Response Relationship, Drug; Drug Eruptions; Drug Therapy, Combination; Gastrointestinal Diseases; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Oligopeptides; Polyethylene Glycols; Protease Inhibitors; Recombinant Proteins; Ribavirin; Severity of Illness Index	2013
Management of anaemia and other treatment complications. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2013, Sep-30, Volume: 45 Suppl 5 Topics: Anemia; Antiviral Agents; Contraindications; Drug Eruptions; Drug Therapy, Combination; Dysgeusia; Hemorrhoids; Hepatitis C, Chronic; Humans; Interferons; Oligopeptides; Patient Selection; Platelet Count; Polyethylene Glycols; Proline; Pruritus Ani; Ribavirin; Serum Albumin	2013
A review of adverse cutaneous drug reactions resulting from the use of interferon and ribavirin. Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2009, Volume: 23, Issue:10 Topics: Alopecia; Antiviral Agents; Drug Eruptions; Drug Therapy, Combination; Eczema; Hepatitis C; Humans; Interferons; Psoriasis; Ribavirin; Sarcoidosis	2009
Dermatological side effects of hepatitis C and its treatment: patient management in the era of direct-acting antivirals. Journal of hepatology, 2012, Volume: 56, Issue:2 Topics: Antiviral Agents; Drug Eruptions; Hepatitis C; Humans; Interferon-alpha; Oligopeptides; Ribavirin; Skin Diseases	2012
[Side-effects of pegylated interferon plus ribavirin therapy with or without protease inhibitor direct acting antiviral agents during treatment of chronic hepatitis C virus infection]. Orvosi hetilap, 2011, Dec-11, Volume: 152, Issue:50 Topics: Affect; Anemia, Hypochromic; Antiviral Agents; Autoimmune Diseases; Autoimmunity; Cardiovascular System; Clinical Trials as Topic; Drug Eruptions; Drug Synergism; Drug Therapy, Combination; Endocrine System Diseases; Eye; Hepatitis C, Chronic; Humans; Infections; Interferon alpha-2; Interferon-alpha; Neutropenia; Oligopeptides; Polyethylene Glycols; Proline; Protease Inhibitors; Recombinant Proteins; Respiratory System; Ribavirin; Risk Factors; Thrombocytopenia	2011
[New agents for the treatment of hepatitis C]. Enfermedades infecciosas y microbiologia clinica, 2012, Volume: 30, Issue:3 Topics: Anemia; Antiviral Agents; Clinical Trials, Phase III as Topic; Drug Discovery; Drug Eruptions; Drugs, Investigational; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Molecular Targeted Therapy; Multicenter Studies as Topic; Oligopeptides; Polyethylene Glycols; Proline; Protease Inhibitors; Recombinant Proteins; Ribavirin; Spain; Viral Nonstructural Proteins	2012
Maximizing opportunities and avoiding mistakes in triple therapy for hepatitis C virus. Gastroenterology, 2012, Volume: 142, Issue:6 Topics: Anemia, Hypochromic; Antiviral Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Eruptions; Drug Interactions; Drug Therapy, Combination; Gastrointestinal Tract; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Oligopeptides; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; Serine Proteinase Inhibitors; Treatment Outcome	2012
Tongue hyperpigmentation during PEG-interferon-alfa/ribavirin therapy in a non-Caucasian patient with chronic hepatitis C: a case report and review of the literature. International journal of dermatology, 2013, Volume: 52, Issue:5 Topics: Adult; Antiviral Agents; Black People; Drug Eruptions; Hepatitis C, Chronic; Humans; Hyperpigmentation; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Tongue	2013
[Prevention of adverse effects in ribavirin and interferon combination therapy]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 7, Issue:Pt 1 Topics: Abnormalities, Drug-Induced; Anemia; Animals; Antiviral Agents; Cerebral Hemorrhage; Drug Eruptions; Drug Therapy, Combination; Feeding and Eating Disorders; Hepatitis C, Chronic; Humans; Interferons; Ribavirin; Tissue Distribution	2004
Clinical and immunological features of hepatitis C treatment-associated dermatitis in 36 prospective cases. The British journal of dermatology, 2005, Volume: 153, Issue:5 Topics: Antiviral Agents; Drug Eruptions; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin	2005
Sarcoidosis during combined interferon alfa and ribavirin therapy in 2 patients with chronic hepatitis C. Archives of dermatology, 2002, Volume: 138, Issue:4 Topics: Antiviral Agents; Drug Eruptions; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Ribavirin; Sarcoidosis	2002
Ribavirin: adverse drug reactions, 1986 to 1988. The Pediatric infectious disease journal, 1990, Volume: 9, Issue:3 Topics: Bronchial Spasm; Drug Eruptions; Drug Evaluation; Female; Headache; Humans; Infant; Male; Medical Records; Respiratory Syncytial Viruses; Respirovirus Infections; Retrospective Studies; Ribavirin; Ribonucleosides	1990

Trials

6 trial(s) available for ribavirin and Dermatitis Medicamentosa

Article	Year
Dermatological side-effects of telaprevir-based triple therapy for chronic hepatitis C in phase III trials in Japan. The Journal of dermatology, 2013, Volume: 40, Issue:8 Topics: Adult; Aged; Antiviral Agents; Drug Eruptions; Female; Hepatitis C, Chronic; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Japan; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Time Factors; Young Adult	2013
The prospective randomized study on telaprevir at 1500 or 2250 mg with pegylated interferon plus ribavirin in Japanese patients with HCV genotype 1. Journal of gastroenterology, 2015, Volume: 50, Issue:3 Topics: Aged; Anemia; Antiviral Agents; Dose-Response Relationship, Drug; Drug Eruptions; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome	2015
Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in Japan. Journal of hepatology, 2012, Volume: 56, Issue:1 Topics: Adult; Aged; Antiviral Agents; Cohort Studies; Drug Eruptions; Drug Therapy, Combination; Female; Genotype; Hematologic Diseases; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Japan; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome; Young Adult	2012
Evaluation of the adverse effect of premature discontinuation of pegylated interferon α-2b and ribavirin treatment for chronic hepatitis C virus infection: results from Kyushu University Liver Disease Study. Journal of gastroenterology and hepatology, 2012, Volume: 27, Issue:7 Topics: Adult; Age Factors; Antiviral Agents; Drug Administration Schedule; Drug Eruptions; Drug Therapy, Combination; Female; Genotype; Hematologic Diseases; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Mental Disorders; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Sex Factors	2012
Skin reaction in antiviral therapy for chronic hepatitis C: a role for polyethylene glycol interferon? Acta dermato-venereologica, 2004, Volume: 84, Issue:2 Topics: Adult; Amantadine; Antiviral Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Eruptions; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Assessment; Severity of Illness Index; Solvents; Treatment Outcome	2004
High prevalence of cutaneous reactions to interferon alfa plus ribavirin combination therapy in patients with chronic hepatitis C virus. Archives of dermatology, 1999, Volume: 135, Issue:8 Topics: Adult; Antiviral Agents; Drug Eruptions; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Prevalence; Ribavirin	1999

Other Studies

42 other study(ies) available for ribavirin and Dermatitis Medicamentosa

Article	Year
Acneiform eruptions: An unusual dermatological side effect of ribavirin. Dermatologic therapy, 2018, Volume: 31, Issue:5 Topics: Acneiform Eruptions; Adult; Antiviral Agents; Drug Eruptions; Hepatitis C, Chronic; Humans; Male; Ribavirin	2018
Papular Sarcoidosis of the Knees Following Treatment with Interferon Alpha and Ribavirin in a Woman with Hepatitis C. Actas dermo-sifiliograficas, 2019, Volume: 110, Issue:10 Topics: Antiviral Agents; Drug Eruptions; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Knee; Middle Aged; Ribavirin; Sarcoidosis; Skin Diseases	2019
Successful treatment after short course of telaprevir-based therapy in chronic hepatitis C infected patient. The Netherlands journal of medicine, 2013, Volume: 71, Issue:7 Topics: Antiviral Agents; Drug Eruptions; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Viral Load; Withholding Treatment	2013
Cutaneous reactions in patients with chronic hepatitis C treated with peginterferon and ribavirin. Dermatology (Basel, Switzerland), 2014, Volume: 228, Issue:1 Topics: Adult; Age Factors; Alopecia Areata; Antiviral Agents; Drug Eruptions; Drug Therapy, Combination; Eczema; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Polyethylene Glycols; Prospective Studies; Pruritus; Recombinant Proteins; Ribavirin; Time Factors	2014
[Early interruption of triple therapy with telaprevir in chronic hepatitis C due to severe adverse effects does not necessarily lead to treatment failure]. Gastroenterologia y hepatologia, 2015, Volume: 38, Issue:2 Topics: Adult; Aged; Antiviral Agents; Cellulitis; Drug Eruptions; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Oligopeptides; Parotitis; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Sepsis; Staphylococcal Infections; Treatment Outcome; Withholding Treatment	2015
Dermatological side-effects in hepatitis C infected patients under a triple regimen associating pegylated interferon, ribavirin and telaprevir. Journal of the European Academy of Dermatology and Venereology : JEADV, 2016, Volume: 30, Issue:1 Topics: Aged; Antiviral Agents; Biopsy; Drug Eruptions; Female; Hepatitis C; Humans; Interferons; Male; Middle Aged; Oligopeptides; Prospective Studies; Ribavirin; Risk Factors	2016
[Cost-utility analysis of triple therapy with telaprevir in treatment-naïve hepatitis C patients]. Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2014, Sep-16, Volume: 38, Issue:5 Topics: Anemia; Antiviral Agents; Carcinoma, Hepatocellular; Cost-Benefit Analysis; Drug Eruptions; Drug Therapy, Combination; Gastrointestinal Diseases; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Markov Chains; Oligopeptides; Polyethylene Glycols; Prevalence; Quality-Adjusted Life Years; Recombinant Proteins; Ribavirin; Severity of Illness Index; Spain	2014
Efficacy and safety of telaprevir-based antiviral treatment for elderly patients with hepatitis C virus. Oncology, 2014, Volume: 87 Suppl 1 Topics: Adult; Aged; Anemia; Antiviral Agents; Biomarkers; Drug Eruptions; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Incidence; Interferon-alpha; Male; Middle Aged; Oligopeptides; Renal Insufficiency; Ribavirin; Time Factors; Treatment Outcome; Viral Load	2014
Drug eruptions induced by telaprevir in patients with chronic hepatitis C virus genotype 1 infection: a prospective study. Actas dermo-sifiliograficas, 2015, Volume: 106, Issue:3 Topics: Adult; Aged; Disease Progression; Drug Eruptions; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Male; Middle Aged; Oligopeptides; Prospective Studies; Ribavirin; Serine Proteinase Inhibitors; Severity of Illness Index	2015
Costs and Resource Utilization Associated With Anemia and Rash in Chronic Hepatitis C Patients Treated With Direct-Acting Antiviral Agents in the United States. Clinical therapeutics, 2015, Volume: 37, Issue:8 Topics: Adult; Aged; Anemia; Antiviral Agents; Databases, Factual; Drug Costs; Drug Eruptions; Drug Therapy, Combination; Female; Health Care Costs; Health Resources; Hepatitis C, Chronic; Humans; Male; Middle Aged; Oligopeptides; Proline; Ribavirin; United States	2015
[Cutaneous adverse events of telaprevir/peginterferon/ribavirin therapy for chronic hepatitis C: A multicenter prospective cohort study]. Annales de dermatologie et de venereologie, 2016, Volume: 143, Issue:5 Topics: Adult; Aged; Antiviral Agents; Cohort Studies; Drug Eruptions; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Young Adult	2016
Eruptive seborrheic keratoses secondary to telaprevir-related dermatitis. Cutis, 2016, Volume: 98, Issue:2 Topics: Aged; Antiviral Agents; Drug Eruptions; Facial Dermatoses; Female; Hepatitis C, Chronic; Humans; Interferons; Keratosis, Seborrheic; Oligopeptides; Ribavirin	2016
Exacerbation of oral lichen planus lesions during treatment of chronic hepatitis C with pegylated interferon and ribavirin. European journal of gastroenterology & hepatology, 2008, Volume: 20, Issue:7 Topics: Aged; Antiviral Agents; Drug Eruptions; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lichen Planus, Oral; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2008
[Lichenoid eruption in a patient with chronic hepatitis C virus infection treated with interferon and ribavirin]. Gastroenterologia y hepatologia, 2009, Volume: 32, Issue:2 Topics: Drug Eruptions; Drug Therapy, Combination; Female; Hand Dermatoses; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lichenoid Eruptions; Middle Aged; Recombinant Proteins; Ribavirin	2009
Etanercept as prophylactic psoriatic therapy before interferon-alpha and ribavirin treatment for active hepatitis C infection. Clinical and experimental dermatology, 2010, Volume: 35, Issue:4 Topics: Antiviral Agents; Drug Eruptions; Drug Therapy, Combination; Etanercept; Hepatitis C, Chronic; Humans; Immunoglobulin G; Interferon-alpha; Male; Middle Aged; Psoriasis; Receptors, Tumor Necrosis Factor; Ribavirin	2010
Repeated episodes of fixed eruption 3 months after discontinuing pegylated interferon-alpha-2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus infection. Clinical and experimental dermatology, 2009, Volume: 34, Issue:8 Topics: Aged; Antiviral Agents; Drug Eruptions; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Recombinant Proteins; Ribavirin	2009
A case of irreversible alopecia associated with ribavirin and peg-interferon therapy. European journal of gastroenterology & hepatology, 2010, Volume: 22, Issue:1 Topics: Aged; Alopecia Areata; Antiviral Agents; Drug Eruptions; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2010
Drug rash with eosinophilia and systemic symptoms due to telaprevir. Dermatology (Basel, Switzerland), 2010, Volume: 221, Issue:4 Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antiviral Agents; Clinical Trials, Phase II as Topic; Drug Eruptions; Drug Therapy, Combination; Dyspnea; Eosinophilia; Exanthema; Female; Fever; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Oligopeptides; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Transaminases; Treatment Outcome	2010
Treatment of psoriasis in patients with hepatitis C virus infection. Clinical and experimental dermatology, 2011, Volume: 36, Issue:4 Topics: Acitretin; Antiviral Agents; Cyclosporine; Drug Eruptions; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferon-alpha; Methotrexate; Psoriasis; Ribavirin	2011
[Cutaneous necrosis due to injection of interferon-alpha 2b in a patient with chronic hepatitis C]. Gastroenterologia y hepatologia, 2011, Volume: 34, Issue:8 Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antiviral Agents; Debridement; Drug Eruptions; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Middle Aged; Necrosis; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Skin Ulcer	2011
When good drugs turn weirdly bad. Cleveland Clinic journal of medicine, 2011, Volume: 78, Issue:7 Topics: Antiviral Agents; Drug Eruptions; Exanthema; Female; Humans; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2011
Rash from hepatitis C treatment. Cleveland Clinic journal of medicine, 2011, Volume: 78, Issue:7 Topics: Antiviral Agents; Drug Eruptions; Exanthema; Female; Humans; Interferon-alpha; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors	2011
A longitudinal cohort study of mucocutaneous drug eruptions during interferon and ribavirin treatment of hepatitis C. Journal of clinical gastroenterology, 2012, Volume: 46, Issue:2 Topics: Antiviral Agents; Cohort Studies; Drug Eruptions; Drug Therapy, Combination; Eczema; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Longitudinal Studies; Male; Middle Aged; Polyethylene Glycols; Ribavirin; Treatment Outcome	2012
[Use of boceprevir and telaprevir in patients with hepatitis C virus infection (practical considerations)]. Gastroenterologia y hepatologia, 2012, Volume: 35, Issue:5 Topics: Antiviral Agents; Drug Eruptions; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Oligopeptides; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin	2012
Diffuse inflammatory lesions in patients treated with interferon alfa and ribavirin for hepatitis C: a series of 20 patients. The British journal of dermatology, 2002, Volume: 147, Issue:6 Topics: Adult; Aged; Antiviral Agents; Drug Eruptions; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Prospective Studies; Ribavirin	2002
Cutaneous side-effects of treatment of chronic hepatitis C by interferon alfa and ribavirin. The British journal of dermatology, 2003, Volume: 149, Issue:3 Topics: Antiviral Agents; Drug Eruptions; Hepatitis C, Chronic; Humans; Interferon-alpha; Ribavirin	2003
Multiple fixed drug eruption with interferon/ribavirin combination therapy for hepatitis C virus infection. Journal of drugs in dermatology : JDD, 2003, Volume: 2, Issue:5 Topics: Antiviral Agents; Drug Eruptions; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferons; Male; Middle Aged; Ribavirin	2003
Severe, generalized nummular eczema secondary to interferon alfa-2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus infection. Archives of dermatology, 2004, Volume: 140, Issue:2 Topics: Antiviral Agents; Drug Eruptions; Drug Therapy, Combination; Eczema; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Ribavirin	2004
Eczema-like lesions and disruption of therapy in patients treated with interferon-alfa and ribavirin for chronic hepatitis C: the value of an interdisciplinary assessment. The British journal of dermatology, 2004, Volume: 150, Issue:5 Topics: Antiviral Agents; Drug Eruptions; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Psychotherapy; Recombinant Proteins; Ribavirin	2004
Cutaneous reactions to interferon and ribavirin. Internal medicine journal, 2004, Volume: 34, Issue:8 Topics: Antiviral Agents; Dermatologic Agents; Drug Eruptions; Drug Therapy, Combination; Hepatitis C, Chronic; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Ribavirin	2004
[Necrotic lesion in a patient with hepatitis C virus liver disease under treatment with pegylated interferon]. Enfermedades infecciosas y microbiologia clinica, 2004, Volume: 22, Issue:8 Topics: Antiviral Agents; Drug Eruptions; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Necrosis; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2004
Meyerson's phenomenon induced by interferon-alfa plus ribavirin in hepatitis C infection. The British journal of dermatology, 2005, Volume: 152, Issue:1 Topics: Adult; Antiviral Agents; Drug Eruptions; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Ribavirin	2005
Diffuse cutaneous eruption due to interferon alfa and ribavirin treatment of chronic hepatitis C. Journal of the European Academy of Dermatology and Venereology : JEADV, 2005, Volume: 19, Issue:3 Topics: Antiviral Agents; Drug Eruptions; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Ribavirin	2005
Meyerson's naevi induced by interferon alfa plus ribavirin combination therapy in hepatitis C infection. The British journal of dermatology, 2005, Volume: 153, Issue:5 Topics: Adult; Antiviral Agents; Drug Eruptions; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Nevus; Recombinant Proteins; Ribavirin; Skin Neoplasms	2005
[Generalized eczema secondary to combined treatment with peginterferon alfa-2a and ribavirin in a patient with chronic hepatitis from the hepatitis C virus]. Actas dermo-sifiliograficas, 2005, Volume: 96, Issue:2 Topics: Adult; Antiviral Agents; Drug Eruptions; Drug Therapy, Combination; Eczema; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2005
Severe allergic eczema due to pegylated alpha-interferon may abate after switching to daily conventional alpha-interferon. Journal of clinical gastroenterology, 2007, Volume: 41, Issue:4 Topics: Adult; Antiviral Agents; Drug Eruptions; Eczema; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2007
Adverse skin reactions due to pegylated interferon alpha 2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus. The Journal of dermatology, 2007, Volume: 34, Issue:8 Topics: Adult; Aged; Antiviral Agents; Drug Eruptions; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2007
Pyoderma gangrenosum and exacerbation of psoriasis resulting from pegylated interferon alpha and ribavirin treatment of chronic hepatitis C. European journal of gastroenterology & hepatology, 2007, Volume: 19, Issue:9 Topics: Antiviral Agents; Drug Eruptions; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Polyethylene Glycols; Psoriasis; Pyoderma Gangrenosum; Recombinant Proteins; Ribavirin	2007
Reversible alopecia universalis secondary to PEG-interferon alpha-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection. European journal of gastroenterology & hepatology, 2007, Volume: 19, Issue:9 Topics: Adult; Alopecia Areata; Antiviral Agents; Drug Eruptions; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2007
Adverse skin reactions associated with hepatitis C treatment: comment. The Journal of dermatology, 2008, Volume: 35, Issue:4 Topics: Antiviral Agents; Drug Eruptions; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Ribavirin	2008
Grover's disease secondary to ribavirin. The British journal of dermatology, 2000, Volume: 142, Issue:6 Topics: Acantholysis; Antiviral Agents; Drug Eruptions; Humans; Male; Middle Aged; Ribavirin	2000
Cutaneous sarcoidosis during interferon alfa and ribavirin treatment of hepatitis C virus infection: two cases. The British journal of dermatology, 2002, Volume: 146, Issue:2 Topics: Adult; Antiviral Agents; Drug Eruptions; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Ribavirin; Sarcoidosis	2002